(1R,2R,3R)-(4S)-AMino-1,2,3-trihydroxy-(5R)-iodocyclopentane 3,4-CarbaMate 1,2-Cyclohexyl Ketal
- CAS No.
- Chemical Name:
- (1R,2R,3R)-(4S)-AMino-1,2,3-trihydroxy-(5R)-iodocyclopentane 3,4-CarbaMate 1,2-Cyclohexyl Ketal
- Synonyms
- (1R,2R,3R)-(4S)-AMino-1,2,3-trihydroxy-(5R)-iodocyclopentane 3,4-CarbaMate 1,2-Cyclohexyl Ketal;(1R,2R,3R,4S,5R)-Hexahydro-7'-iodo-spiro[cyclohexane-1,2'-[5H-1,3]dioxolo[3,4]cyclopent[1,2-d]oxazol]-5'-one
- CBNumber:
- CB32542860
- Molecular Formula:
- C12H16INO4
- Molecular Weight:
- 365.16421
- MDL Number:
- MOL File:
- Mol file
Last updated:2023-04-23 13:52:06
(1R,2R,3R)-(4S)-AMino-1,2,3-trihydroxy-(5R)-iodocyclopentane 3,4-CarbaMate 1,2-Cyclohexyl Ketal price
Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|---|
TRC | A630820 | (1R,2R,3R)-(4S)-Amino-1,2,3-trihydroxy-(5R)-iodocyclopentane3,4-Carbamate1,2-CyclohexylKetal | 25mg | $970 | 2021-12-16 | Buy | |
Medical Isotopes, Inc. | 19917 | (1R,2R,3R)-(4S)-Amino-1,2,3-trihydroxy-(5R)-iodocyclopentane3,4-Carbamate1,2-CyclohexylKetal | 25mg | $1880 | 2021-12-16 | Buy |
(1R,2R,3R)-(4S)-AMino-1,2,3-trihydroxy-(5R)-iodocyclopentane 3,4-CarbaMate 1,2-Cyclohexyl Ketal Preparation Products And Raw materials
Raw materials
Preparation Products
(1R,2R,3R)-(4S)-AMino-1,2,3-trihydroxy-(5R)-iodocyclopentane 3,4-CarbaMate 1,2-Cyclohexyl Ketal Suppliers
Global( 4)Suppliers
Supplier | Tel | Country | ProdList | Advantage | |
---|---|---|---|---|---|
Chemsky(shanghai)International Co.,Ltd. | 021-50135380 | shchemsky@sina.com | China | 32344 | 50 |
S.Z. PhyStandard Bio-Tech. Co., Ltd. | 0755-83725681-603 | China | 4505 | 50 |
Supplier | Advantage |
---|---|
Chemsky(shanghai)International Co.,Ltd. | 50 |
S.Z. PhyStandard Bio-Tech. Co., Ltd. | 50 |
(1R,2R,3R)-(4S)-AMino-1,2,3-trihydroxy-(5R)-iodocyclopentane 3,4-CarbaMate 1,2-Cyclohexyl Ketal
(1R,2R,3R,4S,5R)-Hexahydro-7'-iodo-spiro[cyclohexane-1,2'-[5H-1,3]dioxolo[3,4]cyclopent[1,2-d]oxazol]-5'-one
C12H16INO4
Chiral reagents
Inhibitors
Intermediates